artherosclerosis program (Repair Biotechnologies)

N/A

Report date: 2025/01/26 15:06:48
NME

Base Information

Drug Nameartherosclerosis program (Repair Biotechnologies)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholesterol modulators
TargetsCholesterol
Therapy Area/IndicationsHyperlipoproteinemia Type IIAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRepair Biotechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesRepair Biotechnologies Inc
Inactive CompaniesN/A
Active IndicationsHyperlipoproteinemia Type IIAtherosclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A